Evotec Other Current Liab vs Total Assets Analysis
EVO Stock | USD 5.19 0.05 0.97% |
Evotec SE financial indicator trend analysis is much more than just examining Evotec SE ADR latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evotec SE ADR is a good investment. Please check the relationship between Evotec SE Other Current Liab and its Total Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Other Current Liab vs Total Assets
Other Current Liab vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evotec SE ADR Other Current Liab account and Total Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Evotec SE's Other Current Liab and Total Assets is 0.96. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Total Assets in the same time period over historical financial statements of Evotec SE ADR, assuming nothing else is changed. The correlation between historical values of Evotec SE's Other Current Liab and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of Evotec SE ADR are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Other Current Liab i.e., Evotec SE's Other Current Liab and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.96 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Other Current Liab
Total Assets
Total assets refers to the total amount of Evotec SE assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Evotec SE ADR books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from Evotec SE's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evotec SE ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. At this time, Evotec SE's Selling General Administrative is very stable compared to the past year. As of the 9th of May 2024, Sales General And Administrative To Revenue is likely to grow to 0.26, while Tax Provision is likely to drop about 13.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 618.0M | 751.4M | 781.4M | 820.5M | Depreciation And Amortization | 67.6M | 81.7M | 99.9M | 104.9M |
Evotec SE fundamental ratios Correlations
Click cells to compare fundamentals
Evotec SE Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evotec SE fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.2B | 1.5B | 2.2B | 2.3B | 2.3B | 2.4B | |
Total Stockholder Equity | 477.0M | 722.8M | 1.4B | 1.2B | 1.1B | 1.2B | |
Common Stock Shares Outstanding | 151.5M | 154.9M | 167.1M | 176.7M | 176.9M | 188.4M | |
Liabilities And Stockholders Equity | 1.2B | 1.5B | 2.2B | 2.3B | 2.3B | 2.4B | |
Other Stockholder Equity | 786.9M | 1.0B | 1.4B | 1.4B | 1.4B | 733.8M | |
Other Assets | 58.0M | 62.3M | 79.3M | 1.0 | 1.15 | 1.09 | |
Short Long Term Debt Total | 463.1M | 492.0M | 512.9M | 506.7M | 626.2M | 657.5M | |
Other Current Liab | 53.5M | 65.3M | 74.5M | 87.4M | 73.3M | 77.0M | |
Total Current Liabilities | 179.0M | 208.5M | 324.5M | 337.7M | 464.6M | 487.8M | |
Property Plant And Equipment Net | 239.2M | 337.3M | 484.6M | 650.2M | 806.6M | 846.9M | |
Net Debt | 186.1M | 69.8M | (186.4M) | 91.5M | 115.3M | 121.1M | |
Retained Earnings | (441.2M) | (434.2M) | (216.4M) | (392.4M) | (476.3M) | (500.1M) | |
Accounts Payable | 31.3M | 42.5M | 72.6M | 97.3M | 134.3M | 141.0M | |
Cash | 277.0M | 422.2M | 699.3M | 415.2M | 510.9M | 536.5M | |
Non Current Assets Total | 711.4M | 804.1M | 1.1B | 1.2B | 1.4B | 1.5B | |
Non Currrent Assets Other | 23.7M | 37.4M | 56.8M | 74.1M | 95.2M | 100.0M | |
Cash And Short Term Investments | 321.7M | 492.2M | 858.5M | 730.0M | 604.1M | 634.3M | |
Short Term Investments | 44.6M | 70.1M | 159.2M | 314.8M | 93.2M | 74.6M | |
Non Current Liabilities Total | 524.9M | 531.6M | 533.0M | 732.4M | 714.6M | 750.3M | |
Other Current Assets | 3.8M | 6.5M | 20.7M | 40.2M | 64.1M | 67.3M | |
Total Liab | 703.9M | 740.0M | 857.5M | 1.1B | 1.2B | 1.2B | |
Total Current Assets | 469.5M | 658.8M | 1.1B | 1.1B | 903.2M | 948.3M | |
Short Term Debt | 20.7M | 30.0M | 50.6M | 16.4M | 149.1M | 156.5M | |
Common Stock | 150.9M | 163.9M | 176.6M | 177.0M | 177.2M | 128.1M | |
Current Deferred Revenue | 73.4M | 70.6M | 126.8M | 136.7M | 107.9M | 113.2M | |
Net Receivables | 124.1M | 136.9M | 176.8M | 256.7M | 204.1M | 214.3M | |
Inventory | 10.7M | 13.6M | 25.8M | 29.8M | 30.9M | 32.4M | |
Good Will | 255.9M | 247.4M | 257.6M | 274.8M | 275.6M | 289.4M | |
Intangible Assets | 117.0M | 98.0M | 30.9M | 23.8M | 15.5M | 14.7M | |
Accumulated Other Comprehensive Income | (19.6M) | (37.5M) | (12.6M) | (37.4M) | (30.6M) | (32.2M) | |
Other Liab | 93.2M | 82.6M | 69.6M | 70.7M | 63.6M | 61.8M | |
Net Tangible Assets | 79.0M | 102.9M | 375.9M | 1.1B | 1.3B | 1.3B | |
Long Term Debt | 324.9M | 331.0M | 326.3M | 328.3M | 377.5M | 254.0M | |
Capital Lease Obligations | 131.9M | 145.6M | 150.4M | 176.8M | 203.3M | 112.1M | |
Net Invested Capital | 808.3M | 1.1B | 1.7B | 1.5B | 1.7B | 1.1B | |
Short Long Term Debt | 6.3M | 15.4M | 36.1M | 1.6M | 1.4M | 1.3M | |
Net Working Capital | 290.6M | 450.4M | 776.4M | 736.0M | 846.4M | 888.7M | |
Property Plant Equipment | 89.3M | 238.0M | 335.7M | 484.6M | 557.3M | 585.2M | |
Long Term Investments | 41.3M | 59.0M | 287.0M | 150.3M | 172.9M | 124.7M | |
Capital Stock | 150.9M | 163.9M | 176.6M | 177.0M | 203.5M | 179.8M |
Pair Trading with Evotec SE
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evotec SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will appreciate offsetting losses from the drop in the long position's value.Moving against Evotec Stock
0.81 | ELYM | Eliem Therapeutics | PairCorr |
0.71 | HOOK | Hookipa Pharma | PairCorr |
0.63 | ELDN | Eledon Pharmaceuticals | PairCorr |
0.57 | ZURA | Zura Bio Limited Financial Report 10th of May 2024 | PairCorr |
0.5 | VRCA | Verrica Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Evotec SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evotec SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evotec SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evotec SE ADR to buy it.
The correlation of Evotec SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evotec SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evotec SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evotec SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Evotec Stock analysis
When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Evotec SE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.25) | Revenue Per Share 2.2085 | Quarterly Revenue Growth (0.16) | Return On Assets 0.0003 | Return On Equity (0.07) |
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.